New Medical Cannabis CME Course Provides Evidence-based Review of Medical Cannabis and Approved Uses of Cannabinoids in Medical Practice
(PRUnderground) September 16th, 2020
Cannabis use has become increasingly common across the U.S. as legalization for medical and recreational purposes expands to more states. With this growth in cannabis use and access, as well as increased attention to cannabis and cannabinoid treatments in medical practice, providers should be prepared to have more conversations with patients about its use.
One barrier to medical cannabis education has been a lack of evidence-based and accredited continuing medical education resources around the topic of cannabis. Addressing that lack, Med-Challenger has launched a new Cannabis CME Course – one of the first courses to fill this clinical knowledge gap with the current science and practical guidelines involving medical cannabis in patient care.
One recent article on cannabis education says that the changing landscape of cannabis legislation throughout the U.S. has affected the prevalence and perceptions of safety and harms of cannabis use. With increasing frequency, patients are turning to providers to inquire about a full spectrum of cannabis effects, from medical use to potential harms. Given the widespread use of cannabis to manage symptoms of chronic pain at the same time as the country is facing an opioid epidemic, it is not uncommon for patients to have questions about use of cannabis and opioids for pain. It is imperative that primary care providers understand the evidence to engage in balanced discussions with patients. Additionally, primary care providers require tools to assess for problem cannabis use, as well as have a mechanism for referring patients for treatment if indicated. It is crucial that the medical community deliver consistent, evidence-based assessment, treatment, prevention and harm-reduction messaging to dispel myths and prevent potential public health problems related to cannabis use.
Says Robert Anderson, Med-Challenger’s CEO, “once again, Med-Challenger is on the forefront of providing timely, practical, evidence based tools – our Cannabis CME course helps demystify medical cannabis for physicians and their patients’ education.”
Med-Challenger’s new Cannabis CME course provides a comprehensive overview of cannabis terminology, pharmacology, benefits, harms, and risk mitigation strategies to help providers engage in these discussions with their patients.
Topics such as the endocannabinoid system, cannabis pharmacogenetics, FDA-approved cannabis medications and practical applications of medical cannabis for ailments such as chronic pain and opioid withdrawal are discussed, amongst many others. The course consists of video-based modules with post-viewing self-assessment questions and answers. The course is intended for all healthcare providers and is authored by practicing physicians Kevin Smith, MD, MPH and Greg Smith, MD, MPH. Completion of the materials and assessments provides AMA Category 1 physician CME credits and ANCC nurse “contact hour” credits.
“We’re thrilled that Med-Challenger, with their quarter-century history of unparalleled online medical education has turned their formidable resources to this essential emergent topic,” says Deke Cloyd, CEO of Terre Sevyn and a leading authority on cannabinoid treatments in medical practice.
Med-Challenger’s unique subscription offer allows physicians, nurse practitioners, registered nurses, physician assistants, and other clinicians working in Emergency Medicine, Family Medicine, Internal Medicine, Pediatrics, Pediatric Emergency Medicine, Obstetrics and Gynecology, or Urgent Care to maintain constant CME and certification preparation online.
About Challenger Corporation
Challenger Corporation is a provider of medical education, review and assessment tools for physicians, physician assistants, and nursing professions, including leading residencies, nursing schools, and medical schools world-wide.Press Contact
Original Press Release.